College of American Pathologists (CAP) microbiology committee perspective: The need for verification studies
- Christina M. Wojewoda,
- Neil W. Anderson,
- Romney M. Humphries,
- Isabella W. Martin,
- Blaine A. Mathison,
- Allison R. McMullen
- University of Vermont,
- Washington University St. Louis,
- Accelerate Diagnostics, Inc.,
- Dartmouth College,
- University of Utah,
Scholary Output:
Contribution to journal
Letter
Peer-review
Open access
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Article number
e02105-19Journal (Volume, Issue Number)
Journal of clinical microbiology (Volume 58, Issue 4)Publication milestones
- Published - 2020
Publication status
Published - 2020
ISSN
0095-1137Publication IDs
- Scopus: 85082505514
- PubMed: 32213577
Publication metrics
Metrics
SciVal
Author count
19
SciVal
Paper percentile
50
Fractional count
1
Fractional count
0.05
Fractional count
18
Fractional count
0.95
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
6
Funding Details
ACKNOWLEDGMENTS This letter was submitted with approval from the College of American Pathologists. Dr. Romney M. Humphries is employed by Accelerate Diagnostics, Inc., and owns stocks in the company. Dr. Richard B. Thomson serves as a consultant for Accelerate Diagnostics, Inc., and is the Chair of the Microbiology Expert Panel for the CLSI. Dr. Dan D. Rhoads receives research funding for work on novel antibacterial agents through Shionogi Inc., Tetraphase Pharmaceuticals Inc., and Venatorx Pharmaceuticals. The other authors have no relevant conflicts of interest.
FundersFunding numbers
Microbiology Expert Panel for the CLSI
-Tetraphase Pharmaceuticals Inc.
-Venatorx Pharmaceuticals
-College of American Pathologists Foundation
-Shionogi
-